The Effects of 6-Month Vitamin D Supplementation during the Non-Surgical Treatment of Periodontitis in Vitamin-D-Deficient Patients: A Randomized Double-Blind Placebo-Controlled Study

Marina Perić, Dominique Maiter, Etienne Cavalier, Jérôme F Lasserre, Selena Toma, Marina Perić, Dominique Maiter, Etienne Cavalier, Jérôme F Lasserre, Selena Toma

Abstract

Background: This study assessed the effects of weekly vitamin D (VD) supplementation on clinical and biological parameters after scaling and root planning (SRP) in the treatment of periodontitis and served to validate the VD dosage regimen.

Methods: It was a monocentric, randomized, double-blind, placebo-controlled clinical trial with 6 months follow-up. Healthy Caucasian periodontitis patients presenting serum 25(OH) vitamin D3 below 30 ng/mL were randomly allocated to test group (SRP + VD 25,000 international units (IU)/week) or the control group (SRP + placebo).

Results: A total of 59 patients were screened, 27 were included and 26 completed 3 months (M) and 21 completed 6M control. Test (n = 13) and control groups (n = 14) had similar 25(OH) vitamin D3 levels at baseline (17.6 ± 7.4 vs. 14.4 ± 5.2, respectively). After one month, there was a significant difference between groups (32.9 ± 5.2 vs. 16.1 ± 4.7), also seen at M3 and M6 (t-test, p < 0.001). Periodontal treatment was successful in both groups, since it resulted in a reduction of all measured clinical parameters at M3 and M6 (probing pocket depth (PPD), full mouth bleeding and plaque). However, the reduction in PPD was greater in the test group.

Conclusions: In this short-term pilot study, no significant differences were observed between two groups. However, supplementation with VD tended to improve the treatment of periodontitis in patients with initial 25(OH) vitamin D3 < 30 ng/mL and proved safe and efficacious. NCT03162406.

Keywords: non-surgical periodontal treatment; periodontal disease; periodontitis; serum vitamin D; vitamin D deficiency; vitamin D supplementation.

Conflict of interest statement

The authors declare no conflict of interest in relation to this paper. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
25(OH) vitamin D3 status over study timepoints. The p- values show inter-group difference at M0, M3 and M6 timepoints. * Significant effect of intensity.

References

    1. Sanz M., Van Winkelhoff A.J. Periodontal infections: Understanding the complexity—Consensus of the Seventh European Workshop on Periodontology. J. Clin. Periodontol. 2011;38(Suppl. S11):3–6. doi: 10.1111/j.1600-051X.2010.01681.x.
    1. Hajishengallis G., Korostoff J.M. Revisiting the Page & Schroeder model: The good, the bad and the unknowns in the periodontal host response 40 years later. Periodontology 2000. 2017;75:116–151. doi: 10.1111/prd.12181.
    1. Kassebaum N.J., Bernabé E., Dahiya M., Bhandari B., Murray C.J.L., Marcenes W. Global burden of severe periodontitis in 1990–2010: A systematic review and meta-regression. J. Dent. Res. 2014;93:1045–1053. doi: 10.1177/0022034514552491.
    1. Bouchard P., Carra M.C., Boillot A., Mora F., Rangé H. Risk factors in periodontology: A conceptual framework. J. Clin. Periodontol. 2016;44:125–131. doi: 10.1111/jcpe.12650.
    1. Genco R.J., Borgnakke W.S. Risk factors for periodontal disease. Periodontology 2000. 2013;62:59–94. doi: 10.1111/j.1600-0757.2012.00457.x.
    1. Antonoglou G.N., Knuuttila M., Niemela O., Raunio T., Karttunen R., Vainio O., Hedberg P., Ylöstalo P., Tervonen T. Low serum level of 1,25(OH)2D is associated with chronic periodontitis. J. Periodontal Res. 2014;50:274–280. doi: 10.1111/jre.12207.
    1. Teles F.R., Teles R.P., Martin L., Socransky S.S., Haffajee A.D. Relationships Among Interleukin-6, Tumor Necrosis Factor-α, Adipokines, Vitamin D, and Chronic Periodontitis. J. Periodontol. 2012;83:1183–1191. doi: 10.1902/jop.2011.110346.
    1. Bullon P., Newman H.N., Battino M. Obesity, diabetes mellitus, atherosclerosis and chronic periodontitis: A shared pathology via oxidative stress and mitochondrial dysfunction? Periodontology 2000. 2013;64:139–153. doi: 10.1111/j.1600-0757.2012.00455.x.
    1. Cannell J., Grant W.B., Holick M.F. Vitamin D and inflammation. Derm. Endocrinol. 2014;6:e983401. doi: 10.4161/19381980.2014.983401.
    1. Agrawal D.K., Yin K. Vitamin D and inflammatory diseases. J. Inflamm. Res. 2014;7:69. doi: 10.2147/JIR.S63898.
    1. Mangin M., Sinha R., Fincher K. Inflammation and vitamin D: the infection connection. Inflamm. Res. 2014;63:803–819. doi: 10.1007/s00011-014-0755-z.
    1. Autier P., Boniol M., Pizot C., Mullie P. Vitamin D status and ill health: A systematic review. Lancet Diabetes Endocrinol. 2014;2:76–89. doi: 10.1016/S2213-8587(13)70165-7.
    1. Dietrich T., Nunn M., Dawson-Hughes B., Bischoff-Ferrari H.A. Association between serum concentrations of 25-hydroxyvitamin D and gingival inflammation. Am. J. Clin. Nutr. 2005;82:575–580. doi: 10.1093/ajcn/82.3.575.
    1. Dietrich T., Joshipura K., Dawson-Hughes B., A Bischoff-Ferrari H. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am. J. Clin. Nutr. 2004;80:108–113.
    1. Pinto J.P.N.S., Goergen J., Muniz F.W.M.G., Haas A.N. Vitamin D levels and risk for periodontal disease: A systematic review. J. Periodontal Res. 2018;53:298–305. doi: 10.1111/jre.12531.
    1. Perić M., Cavalier E., Toma Š., Lasserre J.F. Serum vitamin D levels and chronic periodontitis in adult, Caucasian population-a systematic review. J. Periodontal Res. 2018;53:645–656. doi: 10.1111/jre.12560.
    1. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann. Intern. Med. 2010;152:726–732. doi: 10.7326/0003-4819-152-11-201006010-00232.
    1. Armitage G.C. Development of a Classification System for Periodontal Diseases and Conditions. Ann. Periodontol. 1999;4:1–6. doi: 10.1902/annals.1999.4.1.1.
    1. Flemmig T.F. Periodontitis. Ann. Periodontol. 1999;4:32–37. doi: 10.1902/annals.1999.4.1.32.
    1. Cavalier E., Faché W., Souberbielle J.-C. A Randomised, Double-Blinded, Placebo-Controlled, Parallel Study of Vitamin D3 Supplementation with Different Schemes Based on Multiples of 25,000 IU Doses. Int. J. Endocrinol. 2013;2013:327265. doi: 10.1155/2013/327265.
    1. O’Leary T., Drake R.B., Naylor J.E. The Plaque Control Record. J. Periodontol. 1972;43:38. doi: 10.1902/jop.1972.43.1.38.
    1. Ainamo J., Bay I. Problems and proposals for recording gingivitis and plaque. Int. Dent. J. 1975;25:229–235.
    1. Bartold P.M., Van Dyke T.E. Host modulation: Controlling the inflammation to control the infection. Periodontology 2000. 2017;75:317–329. doi: 10.1111/prd.12169.
    1. Herrmann M., Farrell C.-J.L., Pusceddu I., Cabello N.F., Cavalier E. Assessment of vitamin D status—A changing landscape. Clin. Chem. Lab. Med. 2017;55:3–26. doi: 10.1515/cclm-2016-0264.
    1. Spiro A., Buttriss J.L. Vitamin D: An overview of vitamin D status and intake in Europe. Nutr. Bull. 2014;39:322–350. doi: 10.1111/nbu.12108.
    1. Hilger J., Friedel A., Herr R., Rausch T., Roos F., Wahl D.A., Pierroz D.D., Weber P., Hoffmann K. A systematic review of vitamin D status in populations worldwide. Br. J. Nutr. 2013;111:23–45. doi: 10.1017/s0007114513001840.
    1. Wahl D.A., Cooper C., Ebeling P.R., Eggersdorfer M., Hilger J., Hoffmann K., Josse R., Kanis J.A., Mithal A., Pierroz D.D., et al. A global representation of vitamin D status in healthy populations. Arch. Osteoporos. 2012;7:155–172. doi: 10.1007/s11657-012-0093-0.
    1. Hoge A., Donneau A.-F., Streel S., Kolh P., Chapelle J.-P., Albert A., Cavalier E., Guillaume M. Vitamin D deficiency is common among adults in Wallonia (Belgium, 51°30′ North): Findings from the Nutrition, Environment and Cardio-Vascular Health study. Nutr. Res. 2015;35:716–725. doi: 10.1016/j.nutres.2015.06.005.
    1. Cavalier E., Jandrain B., Coffiner M., Da Silva S., De Niet S., Vanderbist F., Souberbielle J.-C. A Randomised, Cross-Over Study to Estimate the Influence of Food on the 25-Hydroxyvitamin D3 Serum Level after Vitamin D3 Supplementation. Nutrients. 2016;8:309. doi: 10.3390/nu8050309.
    1. De Niet S., Coffiner M., Da Silva S., Jandrain B., Souberbielle J.-C., Cavalier E. A Randomized Study to Compare a Monthly to a Daily Administration of Vitamin D3 Supplementation. Nutrients. 2018;10:659. doi: 10.3390/nu10060659.
    1. Buduneli N., Kinane D.F. Host-derived diagnostic markers related to soft tissue destruction and bone degradation in periodontitis. J. Clin. Periodontol. 2011;38:85–105. doi: 10.1111/j.1600-051X.2010.01670.x.
    1. Stadler A.F., Angst P.D.M., Arce R.M., Gomes S.C., Oppermann R.V., Susin C. Gingival crevicular fluid levels of cytokines/chemokines in chronic periodontitis: a meta-analysis. J. Clin. Periodontol. 2016;43:727–745. doi: 10.1111/jcpe.12557.
    1. Preshaw P.M., Taylor J. How has research into cytokine interactions and their role in driving immune responses impacted our understanding of periodontitis? J. Clin. Periodontol. 2011;38:60–84. doi: 10.1111/j.1600-051X.2010.01671.x.
    1. Slominski A.T., Kim T.-K., Shehabi H.Z., Semak I., Tang E.K.Y., Nguyen M.N., Benson H.A.E., Korik E., Janjetovic Z., Chen J., et al. In vivo evidence for a novel pathway of vitamin D 3 metabolism initiated by P450scc and modified by CYP27B1. FASEB J. 2012;26:3901–3915. doi: 10.1096/fj.12-208975.
    1. Slominski A.T., Li W., Kim T.-K., Semak I., Wang J., Zjawiony J.K., Tuckey R.C. Novel activities of CYP11A1 and their potential physiological significance. J. Steroid Biochem. Mol. Boil. 2014;151:25–37. doi: 10.1016/j.jsbmb.2014.11.010.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren